KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Revenue: 2016-2024

Historic Revenue for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to $3.2 billion.

  • Moderna's Revenue fell 45.44% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 55.50%. This contributed to the annual value of $3.2 billion for FY2024, which is 52.75% down from last year.
  • Per Moderna's latest filing, its Revenue stood at $3.2 billion for FY2024, which was down 52.75% from $6.8 billion recorded in FY2023.
  • Moderna's Revenue's 5-year high stood at $19.3 billion during FY2022, with a 5-year trough of $803.0 million in FY2020.
  • Its 3-year average for Revenue is $9.8 billion, with a median of $6.8 billion in 2023.
  • As far as peak fluctuations go, Moderna's Revenue surged by 2,200.25% in 2021, and later tumbled by 64.45% in 2023.
  • Over the past 5 years, Moderna's Revenue (Yearly) stood at $803.0 million in 2020, then surged by 2,200.25% to $18.5 billion in 2021, then grew by 4.29% to $19.3 billion in 2022, then slumped by 64.45% to $6.8 billion in 2023, then slumped by 52.75% to $3.2 billion in 2024.